To inform NHS Commissioning Agencies about services of established or generally accepted value in the diagnosis and management of men with prostate cancer. To identify where possible their resource costs and comment on their cost-effectiveness. To identify areas where current ongoing research has not yet reached a conclusion. To indicate areas where there is a need for further research.